DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 2,240.00
+40.00 (1.82%)
Aug 24, 2026, 3:30 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 71.64 billion as of August 24, 2026. Its market cap has decreased by -48.27% in one year.
Market Cap
71.64B
Enterprise Value
102.74B
Revenue
128.38B
Ranking
n/a
PE Ratio
8.23
Stock Price
2,240.00
ChartMarket Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 71.64B, a decrease of -64.25%. That is a compound annual growth rate of -49.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 71.64B | -38.80% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.72T |
| Celltrion | 44.10T |
| ALTEOGEN | 22.28T |
| Samsung Epis Holdings | 8.94T |
| Prestige BioPharma | 72.96B |
| Ildong Holdings | 72.16B |
| Ray Co., Ltd. | 70.85B |
| PharmGen Science | 70.66B |